SCHEMBL6531606

SCHEMBL6531606

CCOc1ccc(-c2ccc(C=Cc3nc(-c4ccc(Cl)cc4Cl)c[nH]3)cc2)cc1.Clc1ccc(-c2c[nH]c(C=Cc3ccc(Br)cc3)n2)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.38
TP53 P04637 4/20 0.38
THRB P10828 1/20 0.38
KDM4E B2RXH2 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAOB P27338 2/20 0.38
TRPV1 Q8NER1 1/20 0.37
APP P05067 1/20 0.36
PRKAB2 O43741 1/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA2 P54646 1/20 0.36
PRKAA1 Q13131 1/20 0.36
PRKAG3 Q9UGI9 1/20 0.36
PRKAG2 Q9UGJ0 1/20 0.36
PRKAB1 Q9Y478 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
ATP4A P20648 1/20 0.35
ATP4B P51164 1/20 0.35
RELA Q04206 1/20 0.35
ESR1 P03372 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6531603 1.00 MAPT (0.38) MAPTTP53THRBKDM4ETDP1
SCHEMBL1480463 0.95 MAPT (0.41) MAPTTP53KDM4ETDP1MAOB
SCHEMBL1480461 0.95 MAPT (0.41) MAPTTP53KDM4ETDP1MAOB
SCHEMBL1480230 0.92 MAPT (0.43) MAPTTP53KDM4ETDP1MAOB
SCHEMBL1480232 0.92 MAPT (0.43) MAPTTP53KDM4ETDP1MAOB
SCHEMBL1481771 0.87 ATP4A (0.45) SMN1; SMN2ATP4AATP4BAHRNPC1
SCHEMBL1481772 0.87 ATP4A (0.45) SMN1; SMN2ATP4AATP4BAHRNPC1
SCHEMBL1480155 0.86 DHODH (0.39) MAPTKDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL1480157 0.86 DHODH (0.39) MAPTKDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL1481066 0.84 MAPT (0.44) MAPTKDM4EMAOBSMN1; SMN2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004071447-A9 SUBSTITUTED AZOLE DERIVATIVES AS THERAPEUTIC AGENTS TRANSTECH PHARMA INC (US) 2005-10-13 WO disclosed